Literature DB >> 15797155

Patients' interest in discussing cancer risk and risk management with primary care physicians.

Adam H Buchanan1, Celette Sugg Skinner, Susan M Rawl, Barry K Moser, Victoria L Champion, Linda L Scott, Tara S Strigo, Lori Bastian.   

Abstract

Little is known about patients' preferences for discussing cancer risks and risk management with primary care physicians. We sought to determine whether patients want to discuss such topics and what factors are associated with this interest. Participants (375 patients ages 40-85, of diverse race and education level) completed a telephone survey prior to scheduled physician visits. Survey included items on perceived health, perceived cancer risk, education level, and whether participants would like to discuss with a physician their breast, ovarian or colon cancer risk, tamoxifen, cancer genetic counseling, and colon cancer screening. Greater proportions were interested in discussing risks for each cancer, compared with those who were not (P < 0.0001). More participants were interested in discussing mammograms (80%) and cancer genetic counseling (60%) than tamoxifen (49%) or colon cancer screening modalities (43-53%). For many topics, poorer perceived health was associated with greater interest in future discussion; higher education level was associated with less interest.

Entities:  

Mesh:

Year:  2005        PMID: 15797155     DOI: 10.1016/j.pec.2004.04.003

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  10 in total

1.  Breast Cancer Risk Assessment Among Low-Income Women of Color in Primary Care: A Pilot Study.

Authors:  Emily E Anderson; Silvia Tejeda; Kimberly Childers; Melinda R Stolley; Richard B Warnecke; Kent F Hoskins
Journal:  J Oncol Pract       Date:  2015-06-02       Impact factor: 3.840

2.  Cancer genetic risk assessment and referral patterns in primary care.

Authors:  Hetal S Vig; Joanne Armstrong; Brian L Egleston; Carla Mazar; Michele Toscano; Angela R Bradbury; Mary B Daly; Neal J Meropol
Journal:  Genet Test Mol Biomarkers       Date:  2009-12

3.  Perceived susceptibility to chronic kidney disease among high-risk patients seen in primary care practices.

Authors:  L Ebony Boulware; Kathryn A Carson; Misty U Troll; Neil R Powe; Lisa A Cooper
Journal:  J Gen Intern Med       Date:  2009-08-27       Impact factor: 5.128

4.  "You don't have to keep everything on paper": African American women's use of family health history tools.

Authors:  Tess Thompson; Joann Seo; Julia Griffith; Melanie Baxter; Aimee James; Kimberly A Kaphingst
Journal:  J Community Genet       Date:  2013-02-09

5.  Individual breast cancer risk assessment in underserved populations: integrating empirical bioethics and health disparities research.

Authors:  Emily E Anderson; Kent Hoskins
Journal:  J Health Care Poor Underserved       Date:  2012-11

6.  Comparative effectiveness of audit-feedback versus additional physician communication training to improve cancer screening for patients with limited health literacy.

Authors:  Eboni G Price-Haywood; Jewel Harden-Barrios; Lisa A Cooper
Journal:  J Gen Intern Med       Date:  2014-02-04       Impact factor: 5.128

7.  The impact of breast cancer genetic risk assessment on intentions to perform cancer surveillance behaviors.

Authors:  Paul Bennett; Clare Wilkinson; Jim Turner; Gethin Griffith; Barbara France; Kate Brain; Jonathon Gray
Journal:  J Genet Couns       Date:  2007-06-05       Impact factor: 2.537

Review 8.  The construct of breast cancer risk perception: need for a better risk communication?

Authors:  E T M de Jonge; J Vlasselaer; G Van de Putte; J-C Schobbens
Journal:  Facts Views Vis Obgyn       Date:  2009

9.  Patient- and system-related barriers for the earlier diagnosis of colorectal cancer.

Authors:  Terry L Wahls; Ika Peleg
Journal:  BMC Fam Pract       Date:  2009-09-15       Impact factor: 2.497

10.  Educational needs about cancer family history and genetic counseling for cancer risk among frontline healthcare clinicians in New York City.

Authors:  Katarina M Sussner; Lina Jandorf; Heiddis B Valdimarsdottir
Journal:  Genet Med       Date:  2011-09       Impact factor: 8.822

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.